Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1990-2-2
pubmed:abstractText
Bacterial expression of apolipoprotein (apo) B cDNA constructs has been used to map a series of monoclonal antibodies (mAbs) to apoB by immunoblotting. In some cases assignments have been confirmed and refined by (i) semipurification of expressed protein, CNBr digestion, and assignment of the immunoreactive fragments; (ii) controlled digestion of the cDNA with the exonuclease Bal31 and bacterial expression of the truncated proteins that result; or (iii) expression of specific segments of cDNA amplified by the polymerase chain reaction. Forty mAbs were mapped to a minimum of 17 separate determinants on apoB. Tryptic fragments have been used to confirm the epitope assignments. In addition, this approach in conjunction with immunoassay, enables some deductions to be made about the trypsin-accessible regions in low density lipoprotein (LDL). The cleavage pattern obtained predicts retention of structure in the cysteine-rich domain of the amino terminus and also in the LDL receptor binding region. Trypsinized LDL was shown to bind to the LDL receptor by an authentic process, using monoclonal antibodies as competing ligands. In conjunction with the previous paper (Milne, R. W., Theolis, R., Maurice, R., Pease, R. J., Weech, P. K., Rassart, E., Fruchart, J.-C., Scott, J., and Marcel, Y. L. (1989) J. Biol. Chem. 265, 19754-19760) the mapped mAbs have been used to define the receptor-binding domain of apoB100 in LDL.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
5
pubmed:volume
265
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
553-68
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:1688435-Antibodies, Monoclonal, pubmed-meshheading:1688435-Apolipoprotein B-100, pubmed-meshheading:1688435-Apolipoproteins B, pubmed-meshheading:1688435-Base Sequence, pubmed-meshheading:1688435-Binding, Competitive, pubmed-meshheading:1688435-Cloning, Molecular, pubmed-meshheading:1688435-Cyanogen Bromide, pubmed-meshheading:1688435-DNA, pubmed-meshheading:1688435-Epitopes, pubmed-meshheading:1688435-Escherichia coli, pubmed-meshheading:1688435-Gene Expression, pubmed-meshheading:1688435-Genetic Vectors, pubmed-meshheading:1688435-Humans, pubmed-meshheading:1688435-Immunoblotting, pubmed-meshheading:1688435-Lipoproteins, LDL, pubmed-meshheading:1688435-Molecular Sequence Data, pubmed-meshheading:1688435-Peptide Fragments, pubmed-meshheading:1688435-Plasmids, pubmed-meshheading:1688435-Polymerase Chain Reaction, pubmed-meshheading:1688435-Receptors, LDL, pubmed-meshheading:1688435-Recombinant Fusion Proteins, pubmed-meshheading:1688435-Restriction Mapping
pubmed:year
1990
pubmed:articleTitle
Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100.
pubmed:affiliation
Division of Molecular Medicine, Medical Research Council Clinical Research Centre, Harrow, United Kingdom.
pubmed:publicationType
Journal Article